<- Go Home
Enzo Biochem, Inc.
Enzo Biochem, Inc., a life sciences company, engages in the labeling and detection technologies from DNA to whole cell analysis in the United States and internationally. The company offers labels, dyes, antibodies, genomic probes, immunoassays, biochemicals, and proteins are used to label, detect, and visualize a biological target of interest in drug discovery exploration and drug development process development. Its proprietary products and technologies play roles in translational research and drug development areas, including cell biology, genomics, assays, immunohistochemistry, and small molecule chemistry. The company licenses its technology. It serves academic researchers, clinical researchers, biotechnology and pharmaceutical companies, and diagnostic manufacturers. Enzo Biochem, Inc. was incorporated in 1976 and is headquartered in Farmingdale, New York.
Market Cap
$17.0M
Volume
115.4K
Cash and Equivalents
$40.3M
EBITDA
-$8.6M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$13.0M
Profit Margin
44.74%
52 Week High
$1.27
52 Week Low
$0.25
Dividend
30.86%
Price / Book Value
0.36
Price / Earnings
-2.21
Price / Tangible Book Value
0.36
Enterprise Value
-$20.2M
Enterprise Value / EBITDA
2.49
Operating Income
-$9.9M
Return on Equity
12.94%
Return on Assets
-7.46
Cash and Short Term Investments
$40.3M
Debt
$3.1M
Equity
$46.6M
Revenue
$29.1M
Unlevered FCF
-$538.0K
Sector
Health Care Providers and Services
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium